Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only
Recalled by Graviti Pharmaceuticals Private Limited
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Graviti Pharmaceuticals Private Limited has recalled Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on January 28, 2026 and was initiated on January 10, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, with approximately 4212 bottles affected. The company behind the recall is Graviti Pharmaceuticals Private Limited, based in Hyderabad. The FDA describes the product as: “Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.”
Why was Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only recalled?
According to the FDA, the stated reason for the recall is: “Presence of Foreign Substance.”
What should you do?
If you think you may have bought Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, compare it against the product description and identifying codes (Lot# FUB125042G; Exp. 05/13/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Graviti Pharmaceuticals Private Limited or your local health authority.
About this recall
This recall was distributed in U.S. Nationwide. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- January 28, 2026
- Recall started
- January 10, 2026
- Distributed in
- U.S. Nationwide
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only recalled?+
According to the FDA: Presence of Foreign Substance
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0293-2026. Information last synced from the FDA on July 6, 2026.